Dr. Frigault is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Zero Emerson Place, Suite 118
c/o Kerri Tortora
Boston, MA 02114Phone+1 617-726-5765- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2015 - 2017
Johns Hopkins UniversityResidency, Internal Medicine, 2012 - 2015
Perelman School of Medicine at the University of PennsylvaniaClass of 2012
Certifications & Licensure
MA State Medical License 2015 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- TriPRIL CAR T Cells in Multiple Myeloma Start of enrollment: 2021 Oct 05
Roles: Principal Investigator, Contact
- CAR-37 T Cells In Hematologic Malignancies Start of enrollment: 2020 Jun 19
Roles: Contact, Principal Investigator
- Tisagenlecleucel In Primary CNS Lymphoma Start of enrollment: 2019 Dec 11
Roles: Contact, Sponsor-Investigator, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Current and emerging pharmacotherapies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis-like syndrome due to CAR T cell therapy.Zandra E Walton, Matthew J Frigault, Marcela V Maus> ;Expert Opinion on Pharmacotherapy. 2024 Feb 1
- 1 citationsIntraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma.Bryan D Choi, Elizabeth R Gerstner, Matthew J Frigault, Mark B Leick, Christopher W Mount, Leonora Balaj, Sarah Nikiforow, Bob S Carter, William T Curry, Kathleen Gall...> ;The New England Journal of Medicine. 2024 Apr 11
- Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral blood.Won-Ho Lee, Charlotte E Graham, Hadley R Wiggin, Hannah K Nolan, Kiana J Graham, Felix Korell, Mark B Leick, Alexis L Barselau, Estelle Emmanuel-Alejandro, Michael A T...> ;Cytometry. Part B, Clinical Cytometry. 2024 Feb 28
- Join now to see all
Abstracts/Posters
- Post-Transplant Cyclophosphamide in Allogeneic Bone Marrow Transplantation for the Treatment of Benign Hematologic DiseasesMatthew J. Frigault, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...Matthew J. Frigault, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin LymphomaMatthew J. Frigault, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Management of CAR T-Cell Toxicities: Concordance and Divergence between Healthcare Providers and Expert Consensus Recommendations61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Advances in CAR T-Cell Therapy for Leukemia, Lymphoma, and Myeloma: Where We Are and Where We Are Going61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Engineering an Optimized Trimeric APRIL-Based CAR to Broaden Targetability of Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Investigational CAR-T Shows Promise for Advanced Multiple MyelomaJune 5th, 2022- Arcellx Provides Business Updates and Reports First Quarter 2022 Financial ResultsMay 12th, 2022
- Cell Therapy Player Arcellx Now Trading on the NasdaqFebruary 4th, 2022
- Join now to see all
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
